X-ray and mammography equipment vendor Fischer Imaging reported revenue of $19.8 million for the second quarter, ended June 30, 2004, a 64% increase over revenue of $12.1 million for the same period in 2003. Net income for the 2004 second quarter was
X-ray and mammography equipment vendor Fischer Imaging reported revenue of $19.8 million for the second quarter, ended June 30, 2004, a 64% increase over revenue of $12.1 million for the same period in 2003. Net income for the 2004 second quarter was $3.2 million compared with a net loss of $2.4 million in the comparable 2003 period. Results were bolstered, however, by an amended 2002 patent settlement agreement. The amendment provided a one-time payment totaling $4.3 million in lieu of six remaining $0.9 million payments that were due annually through 2010. The gross margin on product sales was 28.5% in the second quarter of 2004, down from 33.1% in the second quarter of 2003. The negative service margin was primarily a result of increased parts usage associated with installed SenoScan systems. The company's quality improvement initiatives and eventual contract maintenance revenue increases are expected to favorably impact both product and service margins over time.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.